-
Je něco špatně v tomto záznamu ?
Consensus statements on the approach to patients in a methanol poisoning outbreak
H. Hassanian-Moghaddam, N. Zamani, DM. Roberts, J. Brent, K. McMartin, C. Aaron, M. Eddleston, PI. Dargan, K. Olson, L. Nelson, A. Bhalla, P. Hantson, D. Jacobsen, B. Megarbane, M. Balali-Mood, NA. Buckley, S. Zakharov, R. Paasma, B. Jarwani, A....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, přehledy
Grantová podpora
NV16-27075A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Medline Complete (EBSCOhost)
od 2005-01-01 do Před 1 rokem
- MeSH
- alkoholické nápoje otrava MeSH
- antidota aplikace a dávkování MeSH
- dialýza ledvin metody MeSH
- epidemický výskyt choroby statistika a číselné údaje MeSH
- lidé MeSH
- methanol otrava MeSH
- otrava epidemiologie terapie MeSH
- třídění pacientů MeSH
- zakázané drogy otrava MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Background: Methanol poisoning is an important cause of mortality and morbidity worldwide. Although it often occurs as smaller sporadic events, epidemic outbreaks are not uncommon due to the illicit manufacture and sale of alcoholic beverages.Objective: We aimed to define methanol poisoning outbreak (MPO), outline an approach to triaging an MPO, and define criteria for prioritizing antidotes, extracorporeal elimination treatments (i.e., dialysis), and indications for transferring patients in the context of an MPO.Methods: We convened a group of experts from across the world to explore geographical, socio-cultural and clinical considerations in the management of an MPO. The experts answered specific open-ended questions based on themes aligned to the goals of this project. This project used a modified Delphi process. The discussion continued until there was condensation of themes.Results: We defined MPO as a sudden increase in the number of cases of methanol poisoning during a short period of time above what is normally expected in the population in that specific geographic area. Prompt initiation of an antidote is necessary in MPOs. Scarce hemodialysis resources require triage to identify patients most likely to benefit from this treatment. The sickest patients should not be transferred unless the time for transfer is very short. Transporting extracorporeal treatment equipment and antidotes may be more efficient.Conclusion: We have developed consensus statements on the response to a methanol poisoning outbreak. These can be used in any country and will be most effective when they are discussed by health authorities and clinicians prior to an outbreak.
Department of Acute Medicine Oslo University Hospital University of Oslo Oslo Norway
Department of Anesthesiology and ICU Pärnu County Hospital Pärnu Estonia
Department of Clinical biochemistry and pharmacology Tomas Bata Hospital ZLÍN Czech Republic
Department of Emergency Medicine Kerman University of Medical Sciences Kerman Iran
Department of Emergency Medicine Rutgers New Jersey Medical School Newark NJ USA
Department of Emergency Medicine VSGH Ahmedabad India
Department of Pharmacology University of Sydney Sydney Australia
Postgraduate Institute of Medical Education and Research Chandigarh India
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023378
- 003
- CZ-PrNML
- 005
- 20201214125902.0
- 007
- ta
- 008
- 201125s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/15563650.2019.1636992 $2 doi
- 035 __
- $a (PubMed)31328583
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Hassanian-Moghaddam, Hossein $u Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Department of Clinical Toxicology, Loghman-Hakim Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- 245 10
- $a Consensus statements on the approach to patients in a methanol poisoning outbreak / $c H. Hassanian-Moghaddam, N. Zamani, DM. Roberts, J. Brent, K. McMartin, C. Aaron, M. Eddleston, PI. Dargan, K. Olson, L. Nelson, A. Bhalla, P. Hantson, D. Jacobsen, B. Megarbane, M. Balali-Mood, NA. Buckley, S. Zakharov, R. Paasma, B. Jarwani, A. Mirafzal, T. Salek, KE. Hovda,
- 520 9_
- $a Background: Methanol poisoning is an important cause of mortality and morbidity worldwide. Although it often occurs as smaller sporadic events, epidemic outbreaks are not uncommon due to the illicit manufacture and sale of alcoholic beverages.Objective: We aimed to define methanol poisoning outbreak (MPO), outline an approach to triaging an MPO, and define criteria for prioritizing antidotes, extracorporeal elimination treatments (i.e., dialysis), and indications for transferring patients in the context of an MPO.Methods: We convened a group of experts from across the world to explore geographical, socio-cultural and clinical considerations in the management of an MPO. The experts answered specific open-ended questions based on themes aligned to the goals of this project. This project used a modified Delphi process. The discussion continued until there was condensation of themes.Results: We defined MPO as a sudden increase in the number of cases of methanol poisoning during a short period of time above what is normally expected in the population in that specific geographic area. Prompt initiation of an antidote is necessary in MPOs. Scarce hemodialysis resources require triage to identify patients most likely to benefit from this treatment. The sickest patients should not be transferred unless the time for transfer is very short. Transporting extracorporeal treatment equipment and antidotes may be more efficient.Conclusion: We have developed consensus statements on the response to a methanol poisoning outbreak. These can be used in any country and will be most effective when they are discussed by health authorities and clinicians prior to an outbreak.
- 650 _2
- $a alkoholické nápoje $x otrava $7 D000434
- 650 _2
- $a antidota $x aplikace a dávkování $7 D000931
- 650 _2
- $a epidemický výskyt choroby $x statistika a číselné údaje $7 D004196
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zakázané drogy $x otrava $7 D013287
- 650 _2
- $a methanol $x otrava $7 D000432
- 650 _2
- $a otrava $x epidemiologie $x terapie $7 D011041
- 650 _2
- $a dialýza ledvin $x metody $7 D006435
- 650 _2
- $a třídění pacientů $7 D014218
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Zamani, Nasim $u Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Department of Clinical Toxicology, Loghman-Hakim Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Roberts, Darren M $u Department of Clinical Pharmacology and Toxicology, and Department of Renal Medicine, St Vincent's Hospital, University of NSW, Sydney, NSW, Australia. NSW Poisons Information Centre, Sydney Children's Hospital, Westmead, Sydney, NSW, Australia.
- 700 1_
- $a Brent, Jeffrey $u School of Medicine, University of Colorado, Aurora, CO, USA.
- 700 1_
- $a McMartin, Kenneth $u Department of Pharmacology, Toxicology and Neuroscience, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, USA.
- 700 1_
- $a Aaron, Cynthia $u Michigan Regional Poison Control Center at Children's Hospital of Michigan, Detroit, MI, USA. Emergency Medicine, Wayne State University School of Medicine, Detroit, MI, USA.
- 700 1_
- $a Eddleston, Michael $u Department of Pharmacology, Toxicology, and Therapeutics, University/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
- 700 1_
- $a Dargan, Paul I $u Department of Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and Faculty of Life Sciences and Medicine, King's College London, London, UK.
- 700 1_
- $a Olson, Kent $u California Poison Control System, San Francisco Division, University of California, San Francisco, San Francisco, CA, USA.
- 700 1_
- $a Nelson, Lewis $u Department of Emergency Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
- 700 1_
- $a Bhalla, Ashish $u Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- 700 1_
- $a Hantson, Philippe $u Université catholique de Louvain, Cliniques universitaires Saint Luc, Bruxelles-Department of Intensive Care, Brussels, Belgium. Université catholique de Louvain, Cliniques universitaires Saint Luc, Bruxelles-Louvain Centre for Toxicology and Applied Pharmacology, Brussels, Belgium.
- 700 1_
- $a Jacobsen, Dag $u Department of Acute Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway.
- 700 1_
- $a Megarbane, Bruno $u Department of Medical and Toxicological Critical Care, Lariboisière Hospital, INSERM UMRS 1144, Paris-Diderot University, Paris, France.
- 700 1_
- $a Balali-Mood, Mahdi $u Medical Toxicology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- 700 1_
- $a Buckley, Nicholas A $u Department of Pharmacology, University of Sydney, Sydney, Australia.
- 700 1_
- $a Zakharov, Sergey $u Department of Occupational Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Toxicological Information Centre, Prague 2, Czech Republic.
- 700 1_
- $a Paasma, Raido $u Department of Anesthesiology and ICU, Pärnu County Hospital, Pärnu, Estonia.
- 700 1_
- $a Jarwani, Bhavesh $u Department of Emergency Medicine, VSGH, Ahmedabad, India.
- 700 1_
- $a Mirafzal, Amirhossein $u Department of Emergency Medicine, Kerman University of Medical Sciences, Kerman, Iran.
- 700 1_
- $a Salek, Tomas $u Department of Clinical biochemistry and pharmacology, Tomas Bata Hospital, ZLÍN, Czech Republic.
- 700 1_
- $a Hovda, Knut Erik $u The Norwegian CBRNE Centre of Medicine, Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.
- 773 0_
- $w MED00013938 $t Clinical toxicology (Philadelphia, Pa.) $x 1556-9519 $g Roč. 57, č. 12 (2019), s. 1129-1136
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31328583 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214125901 $b ABA008
- 999 __
- $a ok $b bmc $g 1595697 $s 1114054
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 57 $c 12 $d 1129-1136 $e 20190722 $i 1556-9519 $m Clinical toxicology $n Clin Toxicol (Phila) $x MED00013938
- GRA __
- $a NV16-27075A $p MZ0
- LZP __
- $a Pubmed-20201125
